News | Rappta Therapeutics

Home
About Us
What is PP2A
Our Technology
Contact Us

News & Articles

No articles at the moment.

Rappta Therapeutics

Rappta Therapeutics is a late preclinical stage biopharmaceutical company. We are working on a first-in-class series of anti-cancer molecules that reactivate a key tumor suppressor, protein phosphatase 2A (PP2A).

Navigate

Home
About Us
What is PP2A
Our Technology
Contact Us

Contact Us

Rappta Therapeutics Oy
Mannerheimintie 12b (Luna House), 00100 Helsinki